Browse > Article
http://dx.doi.org/10.4070/kcj.2012.42.2.100

Higher Plasma Thrombospondin-1 Levels in Patients With Coronary Artery Disease and Diabetes Mellitus  

Choi, Kyu-Young (Departemnt of Cardiology, The Catholic University of Korea College of Medicine)
Kim, Dong-Bin (Departemnt of Cardiology, The Catholic University of Korea College of Medicine)
Kim, Myung-Jun (Departemnt of Physiology, The Catholic University of Korea College of Medicine)
Kwon, Bum-June (Departemnt of Cardiology, The Catholic University of Korea College of Medicine)
Chang, Seo-Yoon (Departemnt of Physiology, The Catholic University of Korea College of Medicine)
Jang, Sung-Won (Departemnt of Cardiology, The Catholic University of Korea College of Medicine)
Cho, Eun-Joo (Departemnt of Cardiology, The Catholic University of Korea College of Medicine)
Rho, Tai-Ho (Departemnt of Cardiology, The Catholic University of Korea College of Medicine)
Kim, Jae-Hyung (Departemnt of Cardiology, The Catholic University of Korea College of Medicine)
Publication Information
Korean Circulation Journal / v.42, no.2, 2012 , pp. 100-106 More about this Journal
Abstract
Background and Objectives: Thrombospondin-1 (TSP-1) is associated with atherosclerosis in animals with diabetes mellitus (DM). But, no study has investigated the role of TSP-1 in human atherosclerosis. This study investigated the relationship among plasma TSP-1 concentration, DM, and coronary artery disease (CAD). Subjects and Methods: The study involved 374 consecutive subjects with suspected CAD, who had undergone coronary angiography to evaluate effort angina. Patients were divided into four groups as follows: DM(-) and CAD(-), DM(-) and CAD(+), DM(+) and CAD(-), and DM(+) and CAD(+). Results: We found that plasma TSP-1 levels were higher in patients with DM(+) and CAD(+) (n=103) than those in other patients (n=271) (p<0.01). A multivariate analysis showed that male gender {odds ratio (OR), 2.728; 95% confidence interval (CI), 1.035-7.187}, high density lipoprotein-cholesterol (OR, 0.925; 95% CI, 0.874-0.980), glycated hemoglobin (OR, 1.373; 95% CI, 1.037-1.817), and plasma TSP-1 (OR, 1.004; 95% CI, 1.000-1.008) levels were independently associated with the presence of CAD in patients with DM. Conclusion: Plasma TSP-1 levels were higher in patients with DM(+) and CAD(+) than those in other patients, and plasma TSP-1 levels were independently associated with the presence of CAD in patients with DM. These findings show a possible link between human plasma TSP-1 concentration and CAD in patients with DM.
Keywords
Thrombospondin-1; Coronary artery disease; Diabetes mellitus;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Baenziger NL, Brodie GN, Majerus PW. A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci U S A 1971;68:240-3.   DOI   ScienceOn
2 Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell BIol 1995;130:503-6.   DOI   ScienceOn
3 Adams JC. Thrombospondins: multifunctional regulators of cell interactions. Annu Rev Cell Dev Biol 2001;17:25-51.   DOI   ScienceOn
4 Ren B, Yee KO, Lawler J, Khosravi-Far R. Regulation of tumor angiogenesis by thrombospondin-1. Biochim Biophys Acta 2006;1765:178-88.
5 Agah A, Kyriakides TR, Lawler J, Bornstein P. The lack of thrombospondin- 1 (TSP1) dictates the course of wound healing in double-TSP1/ TSP2-null mice. Am J Pathol 2002;161:831-9.   DOI   ScienceOn
6 Frangogiannis NG, Ren G, Dewald O, et al. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 2005;111:2935-42.   DOI   ScienceOn
7 Isenberg JS, Romeo MJ, Abu-Asab M, et al. Increasing survival of ischemic tissue by targeting CD47. Circ Res 2007;100:712-20.   DOI   ScienceOn
8 Stenina OI, Krukovets I, Wang K, et al. Increased expression of thrombospondin- 1 in vessel wall of diabetic zucker rat. Circulation 2003; 107:3209-15.   DOI   ScienceOn
9 Raman P, Krukovets I, Marinic TE, Bornstein P, Stenina OI. Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells. J Biol Chem 2007;282:5704-14.   DOI
10 Murphy M, Godson C, Cannon S, et al. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999;274:5830-4.   DOI   ScienceOn
11 Tada H, Kawai H, Ishii H, Nomura K, Urayama T, Isogai S. Thrombospondin modulates adhesion, proliferation and production of extracellular matrix in mesangial cells. Tohoku J Exp Med 1995;177:293-302.   DOI   ScienceOn
12 Poczatek MH, Hugo C, Darley-Usmar V, Murphy-Ullrich JE. Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1. Am J Pathol 2000;157: 1353-63.   DOI   ScienceOn
13 Yevdokimova N, Wahab NA, Mason RM. Thrombospondin-1 is the key activator of TGF-beta1 in human mesangial cells exposed to high glucose. J Am Soc Nephrol 2001;12:703-12.
14 Belmadani S, Bernal J, Wei CC, et al. A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II. Am J Pathol 2007; 171:777-89.   DOI   ScienceOn
15 Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes care 1997;20:1183-97.
16 Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289: 2560-72.   DOI   ScienceOn
17 Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606.   DOI   ScienceOn
18 Majack RA, Goodman LV, Dixit VM. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J Cell Biol 1988;106:415-22.   DOI   ScienceOn
19 Stouffer GA, Hu Z, Sajid M, et al. Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells. Circulation 1998; 97:907-15.   DOI   ScienceOn
20 Kirma C, Akcakoyun M, Esen AM, et al. Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease. Circ J 2007;71:698-702.   DOI   ScienceOn
21 Topol EJ, McCarthy J, Gabriel S, et al. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 2001;104:2641-4.   DOI   ScienceOn
22 Hsu SC, Volpert OV, Steck PA, et al. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res 1996;56:5684-91.
23 Nor JE, Mitra RS, Sutorik MM, Mooney DJ, Castle VP, Polverini PJ. Thrombospondin- 1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. J Vasc Res 2000;37:209-18.   DOI   ScienceOn
24 McGillicuddy FC, O'Toole D, Hickey JA, Gallagher WM, Dawson KA, Keenan AK. TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells. Vascul Pharmacol 2006;44:469-75.   DOI   ScienceOn
25 Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002;347:1916-23.   DOI   ScienceOn
26 Carlson CB, Liu Y, Keck JL, Mosher DF. Influences of the N700S thrombospondin- 1 polymorphism on protein structure and stability. J Biol Chem 2008;283:20069-76.   DOI
27 Stenina OI. Regulation of vascular genes by glucose. Curr Pharm Des 2005;11:2367-81.   DOI   ScienceOn
28 Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-31.   DOI   ScienceOn